my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Medicago is a publicly-traded biotechnology company focused on the development, production and commercialization of protein-based vaccines and biopharmaceuticals using a proprietary manufacturing system developed from its expertise in the genetic engineering of plants.
Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate ... > more
Medicago Inc. and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. "We look forward to working with Cellectis plant science ... > more
Medicago Inc. announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.Under the terms of the research collaboration, Medicago will apply its transient expression system to deve ... > more
Medicago to build $245M production facility in Quebec City
Medicago announced that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago's Quebec City office and laboratories. The project is expected to generate ... more
Medicago Inc. and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. "We look forward to working with Cellectis plant science ... more
Medicago announces research collaboration for the development of a non-influenza vaccine candidate
Medicago Inc. announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.Under the terms of the research collaboration, Medicago will apply its transient expression system to deve ... more
To be a trusted partner in the development and manufacture of critical bioreagents. To be committed to innovative solutions through excellence in research and development. To deliver highest level of quality products and world class services to our customers. To focus on broadering our rang ... more
© 1997-2021 LUMITOS AG, All rights reserved
